Legal risks associated with peptides for practicing physicians

Coverage, in order

1. 5d ago
   
   Healio indie study observational

   Legal risks associated with peptides for practicing physicians

   Physicians prescribing peptides that have not been FDA approved continue to face a myriad of potential legal and regulatory risks. While prescribing FDA-approved semaglutide (Ozempic and Wegovy, Novo Nordisk) and tirzepatide (Zepbound and Mounjaro, Eli Lilly) for their approved uses presents few…

Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.